Goldman Sachs
MD icon

Goldman Sachs’s Pediatrix Medical MD Stock Holding History

Goldman Sachs’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-10,400
Closed -$450K – 5713
2018
Q2 		$450K Buy
+10,400
New +$498K ﹤0.01% 4570
2018
Q1 		– Sell
-74,700
Closed -$3.99M – 6193
2017
Q4 		$3.99M Buy
+74,700
New +$3.52M ﹤0.01% 3216

Other funds holding MD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Goldman Sachs's MD Position: Q1 2026 in Review

Goldman Sachs increased its Pediatrix Medical (MD) stake by 8.2% in Q1 2026, buying an estimated $1.34M and bringing the position to 851,464 shares worth $18.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2521.

Goldman Sachs first reported a position in MD in Q2 2013 and has held it in 52 quarters since. The position peaked at $86M in Q4 2016. 296 funds tracked by Wall St. Rank hold MD as of Q1 2026.

  • Goldman Sachs held 851,464 shares of Pediatrix Medical worth $18.2M as of Q1 2026.
  • Goldman Sachs bought 64,195 Pediatrix Medical shares in Q1 2026, an estimated $1.34M.
  • Pediatrix Medical made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #2521 holding.
  • Goldman Sachs first reported a position in Pediatrix Medical in Q2 2013 and has held it in 52 quarters since.
  • Goldman Sachs's Pediatrix Medical position peaked at $86M in Q4 2016.
  • 296 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.